Johnson & Johnson Services Inc. is the corporate services arm of Johnson & Johnson, a large health care and pharmaceutical company. According to filings, it spends money on lobbying through Hart Health Strategies and reports focusing on biopharma-related issues. The filings indicate small-scale federal lobbying activity totaling about $20,000 through early 2026.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
This client has not yet disclosed issue activity in the available filings.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
No lobbyists are disclosed for this client yet.
The latest disclosures for this client.
HART HEALTH STRATEGIES
Q2YHART HEALTH STRATEGIES
Q1YHART HEALTH STRATEGIES
Q4YThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
This client's filings do not yet disclose named government entities.
HART HEALTH STRATEGIES
Q3YHART HEALTH STRATEGIES
Q2YHART HEALTH STRATEGIES
Q1Y